There will be some demand, but Kybella won’t be a big-selling product like Botox. There will be little or no off-label use in other parts of the body due to the risks cited in my prior post.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”